SBC Medical Group (SBC)
SBC Medical Group (SBC) Stock Price, Analysis & Data
| Bid | 3.05 |
| Market Cap | 375.43M |
| Revenue (ttm) | 175.17M |
| Net Income (ttm) | 49.03M |
| Beta | 0.59 |
| EPS (ttm) | 0.48 |
| PE Ratio (ttm) | 7.63 |
| Forward PE | 7.55 |
| P/B (ttm) | 1.47 |
| P/S (ttm) | 2.15 |
| Earnings Date | Nov 12, 2026 |
| Ask | 3.4 |
| Volume | 347,981 |
| Avg. Volume (20D) | 119,918 |
| Open | 3.19 |
| Previous Close | 3.19 |
| Day's Range | 3.17 - 3.67 |
| 52-Week Range | 2.78 - 5.07 |
| Analyst | n/a |
| Price Target | 8.5 (132.24%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SBC
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold imp...
Financial Performance
In 2025, SBC Medical's revenue was 173.61M, a decrease of -15.48% compared to the previous year's 205.42M. Earnings were 50.99M, an increase of 9.38%.
Financial StatementsAnalyst Forecast
According to 4 analyst ratings, the average rating for SBC stock is "null". The 12-month stock price forecast is 8.5, which is upside of 132.24% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
